Search Results

UDOLAM 300

URSODEOXYCHOLIC ACID 300mg. IP

Send Enquiry

EVERMED

Tablets

Packaging and packing Type

Blister | 10x15

MRP :

₹575

PTR :

₹438.1

PTS :

₹394.29

A hepatoprotective medication is employed in the management and treatment of cholestatic liver disease. (Achufusi, Safadi, & Mahabadi, 2021) The firs... Read More

Composition

URSODEOXYCHOLIC ACID 300mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

A hepatoprotective medication is employed in the management and treatment of cholestatic liver disease. (Achufusi, Safadi, & Mahabadi, 2021) The first choice medication for most cholestatic hepatopathies. (Fernando Bessone, 2016) Counteracts inflammation and bile-acid-induced liver damage. (Fernando Bessone, 2016) Widely recognized as an effective compound in the treatment of chronic hepatitis. (Sakiko Arisawa, 2009) Aids break down cholesterol that has formed into stones in the gallbladder. Protects liver cells from injury caused due to toxic bile acids, and improves liver function. An alternative to cholecystectomy in patients with gallstone disease. (Achufusi T. G., 2021) Shows a significant decrease in the incidence of gallstone disease complications. (Michele Pier Luca Guarino, 2013) Exhibits antioxidant, anti-inflammatory, immunomodulating, and anti-apoptotic effects. (Chao Li, 2020) A beneficial therapeutic agent in various types of liver pathology. (Achufusi, Safadi, & Mahabadi, 2021) Reduces the incidence of biliary pain and acute cholecystitis in patients with symptomatic gallstones. (Michele Pier Luca Guarino S. C., 2013) Delays the development of gastroesophageal varices and progression to cirrhosis. (Angulo, 2002) Improves long-term survival in patients with primary biliary cirrhosis. (Angulo, 2002) Restores gallbladder muscle functions and reduces the biochemical markers of oxidative stress and inflammation. (Michele Pier Luca Guarino P. C., 2007)

Side Effects

Diarrhea, Indigestion, Headache, Nausea, Vomiting

Indication

Primary biliary cirrhosis , Primary sclerosing cholangitis , Cystic fibrosis-associated liver disease , Nonalcoholic fatty liver disease , Hepatitis , Gallbladder stones , Cholestasis

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner